Study during DR Congo’s outbreak found 84% protection from Ebola vaccine
On Aug. 21, 2024, French and Democratic Republic of the Congo (DRC) researchers announced that a real-world study…
Biology | Biotechnology | Disease | Genomics | Infectious Disease | Life Science History | Non-Profit Research
Human Defenses Against Viruses First Evolved Billions of Years Ago, Study Suggests
On Aug. 21, 2024, a research team at the University of Texas at Austin reported that the first…
New insights on how bird flu crosses the species barrier
On Aug. 19, 2024, scientists at the European Molecular Biology Laboratory (EMBL) published research that sheds light on…
Multi-year, 1143-patient genetic study identified unique types of multiple myeloma
On Aug. 19, 2024, an international team of scientists led by researchers from the Translational Genomics Research Institute (TGen) announced…
ECDC recommended enhancing preparedness as more imported cases of clade I mpox highly likely
ON Aug. 16, 2024, the European Centre for Disease Prevention and Control (ECDC) reported that it is highly…
West Nile virus discovered in Michigan, Residents Urged to Protect Themselves from Mosquito Bites
On Aug. 15, 2024, the Oakland County Health Division in Pontiac, Michigan urged residents to protect themselves from mosquito…
Global cancer deaths among men projected to increase by 93% by 2050
On Aug. 15, 2024, a study published in the journal Cancer projected an alarming increase in cancer cases and deaths…
Biotechnology | Disease | Medicine | Vaccine | WHO
WHO declared mpox outbreak a public health emergency of international concern
On Aug. 14, 2024, The World Health Organization declared that the upsurge of mpox in the Democratic Republic…
City birds found to be carriers of antimicrobial resistant bacteria
on Aug. 14, 2024, research led by scientists at the Ineos Oxford Institute for antimicrobial research at Oxford…
Biotechnology | Disease | FDA | Neurology | Therapeutics
Amneal Received U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease
On Aug. 7, 2024, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved CREXONT…
Biotechnology | Disease | FDA | Neurology | Non-Profit Research | Oncology
FDA Approved Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
Study Analyzed Potato-Pathogen ‘Arms Race’ After Irish Famine
On Aug. 5, 2024, North Carolina State University researchers revealed that an examination of the genetic material found…
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Therapeutics
FDA Approved ‘First Gene Therapy’ to Treat Adults with Metastatic Synovial Sarcoma
On Aug. 2, 2024, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra (afamitresgene autoleucel), a gene therapy…
the Lancet standing Commission Report: Dementia prevention, intervention, and care released
On Jul. 31, 2024, the Lancet Standing Commission released its 2024 Dementia prevention, intervention, and care report that…
Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
Accuracy of diagnostic blood tests for Alzheimer’s disease varies
On Jul. 30, 2024, a head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by…
largest population-based study to date supported the survival benefits of immunotherapy for people with metastatic non-small cell lung cancer
On Jul. 29, 2024, a team led by the Barbara Ann Karmanos Cancer Institute and the Wayne State…
FDA approved Guardant Health’ Shield, a test to screen for colorectal cancer
On Jul. 26, 2024, the U.S. Food and Drug Administration (FDA) approved the Guardant Health’s Shield, a test…
Boar’s Head Recalls Ready-To-Eat Liverwurst And Other Deli Meat Products Due to Possible Listeria Contamination
On Jul. 26. 2024, Boar’s Head, a Jarratt, Va., establishment, announced it was recalling all liverwurst product produced…
European Commission Approved Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
On Jul. 25, 2024, Pfizer announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX®…
Successful first-in-human implantation of the BiVACOR Total Artificial Heart by Baylor and THI doctors
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
Scientists identified possible new transmission factor in hospital-acquired Klebsiella infections
On Jul. 22, 2024, scientists at ADA Forsyth Institute (AFI) announced they had identified a critical factor that…
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
Public Health Officials Confirmed First Human Plague Case in Pueblo County, Colorado
On Jul. 9, 2024, officials at the Pueblo Department of Public Health and Environment (PDPHE), in collaboration with…
Study detected bacteria in 35% of commercial tattoos and permanent makeup inks sold in U.S.
On Jul. 2, 2024, a study was released that showed evidence that commercial tattoo and PMU inks are…
Emergent BioSolutions Awarded $250+ Million in Contract to Supply U.S. Government with Four Critical Medical Countermeasure Products
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
Disease | Therapeutics | WHO
WHO releases first-ever clinical treatment guideline for tobacco cessation in adults
On Jul. 2, 2024, the World Health Organization (WHO) recommended a comprehensive set of tobacco cessation interventions, including…
CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
C2N’s Precivity™ Tests are Now Offered Through Mayo Clinic Laboratories
On Jun. 27, 2024, C2N Diagnostics (C2N), has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for…
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics | WHO
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…